Polystyrene microplastic exposure induces insulin resistance in mice via dysbacteriosis and pro-inflammation

Dingjie Huang1, Ying Zhang2, Jianglan Long2

  • 1Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China; Beijing Institute of Clinical Pharmacy, Beijing 100050, China; Beijing Key Laboratory for Evaluation of Rational Drug Use, Beijing 100038, China.

Insights

Polystyrene microplastics (MPs) exposure induced insulin resistance in mice by altering gut bacteria and causing inflammation. This suggests MPs may be environmental contaminants linked to metabolic diseases.

Area of Science:

  • Environmental Science
  • Toxicology
  • Metabolic Diseases

Background:

  • Microplastics (MPs) are emerging contaminants with widespread environmental presence.
  • Limited research exists on the impact of MPs on metabolic diseases, particularly insulin resistance.

Purpose of the Study:

  • To investigate the effects of polystyrene microplastics (PS MPs) on insulin sensitivity in mice.
  • To elucidate the underlying mechanisms by which PS MPs induce insulin resistance.

Main Methods:

  • Mice were fed either a normal chow diet (NCD) or a high-fat diet (HFD) and exposed to PS MPs.
  • Evaluated insulin resistance, plasma lipopolysaccharide, pro-inflammatory cytokines, gut microbiota composition, and PS accumulation in tissues.
  • Analyzed the insulin signaling pathway in liver tissues.

Main Results:

  • PS MP exposure led to insulin resistance in both NCD and HFD groups.
  • Increased plasma lipopolysaccharide and pro-inflammatory cytokines (TNF-α, IL-1β) were observed.
  • Gut microbiota diversity decreased, with an increase in Gram-negative bacteria.
  • Small-sized PS MPs (5 μm) accumulated in liver, kidneys, and blood vessels.
  • Insulin signaling pathway (IRS1, PI3K) was inhibited in the liver.

Conclusions:

  • PS MP exposure induces insulin resistance potentially through gut microbiota dysregulation, tissue accumulation, inflammation, and impaired insulin signaling.
  • Polystyrene microplastics may act as environmental contaminants contributing to metabolic diseases associated with insulin resistance.

Related Concept Videos

Microbial Bioremediation of Plastics01:28

Microbial Bioremediation of Plastics

Polyethylene terephthalate (PET) is a synthetic polymer widely utilized in the packaging industry, particularly for bottles and containers. Due to its chemical stability and durability, PET accumulates in the environment, contributing significantly to plastic pollution. It comprises repeating units of terephthalic acid and ethylene glycol, resulting in a semi-crystalline structure that is resistant to natural degradation processes.A notable breakthrough in plastic biodegradation came with the...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...